Inhibition of cGAS blocked STING phosphorylation and the IFN-inducible cytokines CXCL10 and CCL5 in response to tau, supporting cGAS inhibition as a promising therapeutic approach to improve cognition in AD [47]. The gene discussed is CGAS; the disease is Alzheimer disease.